Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Basket Trial Evaluating the Efficacy of a Combination of Pembrolizumab and Vorinostat in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma

NCT04357873 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT04357873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04357873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Basket Trial Evaluating the Efficacy of a Combination of Pembrolizumab and Vorinostat in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
October 28, 2020
Completion date
November 26, 2024
Enrollment
112 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, cervix cancer, head and neck squamous cell carcinoma, penile cancer, squamous cell lung cancer, vulvar cancer